Table of contents
Volume 95, Issue 12
Published online 12 December 2006 (1611-1721)
Clinical Studies |
Translational Therapeutics |
Molecular Diagnostics |
Genetics and Genomics |
Letter to the Editor |
Corrigendum |
Indexes
Review
First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours FREE
I Van der Auwera, Y Cao, J C Tille, M S Pepper, D G Jackson, S B Fox, A L Harris, L Y Dirix and P B Vermeulen
Br J Cancer 95: 1611-1625; advance online publication, November 21, 2006; doi:10.1038/sj.bjc.6603445
Clinical Studies
Quality of life and sexual function after high-dose or conventional chemotherapy for high-risk breast cancer FREE
K M Malinovszky, A Gould, E Foster, D Cameron, A Humphreys, J Crown and R C F Leonard on behalf of the Anglo Celtic Co-operative Oncology Group
Br J Cancer 95: 1626-1631; doi:10.1038/sj.bjc.6603454
Mortality within 30 days of chemotherapy: a clinical governance benchmarking issue for oncology patients FREE
M E R O'Brien, A Borthwick, A Rigg, A Leary, L Assersohn, K Last, S Tan, S Milan, D Tait and I E Smith
Br J Cancer 95: 1632-1636; doi:10.1038/sj.bjc.6603498
A phase II trial of S-1 monotherapy in metastatic colorectal cancer after failure of irinotecan- and oxaliplatin-containing regimens FREE
H-C Jeung, S Y Rha, B C Cho, N C Yoo, J K Roh, W J Roh, H C Chung and J B Ahn
Br J Cancer 95: 1637-1641; advance online publication, November 14, 2006; doi:10.1038/sj.bjc.6603468
Phase I/II study of S-1 combined with paclitaxel in patients with unresectable and/or recurrent advanced gastric cancer FREE
E Mochiki, T Ohno, Y Kamiyama, R Aihara, N Haga, H Ojima, J Nakamura, H Ohsawa, T Nakabayashi, K Takeuchi, T Asao and H Kuwano and the North Kanto Gastric Cancer Study Group
Br J Cancer 95: 1642-1647; advance online publication, November 28, 2006; doi:10.1038/sj.bjc.6603497
Three-week schedule of irinotecan plus cisplatin in patients with previously untreated extensive-stage small-cell lung cancer FREE
Y S Hong, H R Lee, S Park, S C Lee, I G Hwang, B-B Park, J Lee, J S Ahn, M-J Ahn, H Y Lim and K Park
Br J Cancer 95: 1648-1652; advance online publication, November 28, 2006; doi:10.1038/sj.bjc.6603500
Translational Therapeutics
NFV, an HIV-1 protease inhibitor, induces growth arrest, reduced Akt signalling, apoptosis and docetaxel sensitisation in NSCLC cell lines FREE
Y Yang, T Ikezoe, C Nishioka, K Bandobashi, T Takeuchi, Y Adachi, M Kobayashi, S Takeuchi, H P Koeffler and H Taguchi
Br J Cancer 95: 1653-1662; advance online publication, November 28, 2006; doi:10.1038/sj.bjc.6603435
Histamine, a vasoactive agent with vascular disrupting potential, improves tumour response by enhancing local drug delivery FREE
F Brunstein, J Rens, S T van Tiel, A M M Eggermont and T L M ten Hagen
Br J Cancer 95: 1663-1669; advance online publication, November 14, 2006; doi:10.1038/sj.bjc.6603461
Molecular Diagnostics
The status of CDKN2A alpha (p16INK4A) and beta (p14ARF) transcripts in thyroid tumour progression FREE
A Ferru, G Fromont, H Gibelin, J Guilhot, F Savagner, J M Tourani, J L Kraimps, C J Larsen and L Karayan-Tapon
Br J Cancer 95: 1670-1677; advance online publication, November 21, 2006; doi:10.1038/sj.bjc.6603479
Very low prevalence of germline MSH6 mutations in hereditary non-polyposis colorectal cancer suspected patients with colorectal cancer without microsatellite instability FREE
C M Kets, J H J M van Krieken, K M Hebeda, S J Wezenberg, M Goossens, H G Brunner, M J L Ligtenberg and N Hoogerbrugge
Br J Cancer 95: 1678-1682; advance online publication, November 21, 2006; doi:10.1038/sj.bjc.6603478
The relationship of the neo-angiogenic marker, endoglin, with response to neoadjuvant chemotherapy in breast cancer FREE
M J Beresford, A L Harris, M Ah-See, F Daley, A R Padhani and A Makris
Br J Cancer 95: 1683-1688; doi:10.1038/sj.bjc.6603491
Genetics and Genomics
HapMap-based study of the 17q21 ERBB2 amplicon in susceptibility to breast cancer FREE
P R Benusiglio, P D Pharoah, P L Smith, F Lesueur, D Conroy, R N Luben, G Dew, C Jordan, A Dunning, D F Easton and B A J Ponder
Br J Cancer 95: 1689-1695; advance online publication, November 21, 2006; doi:10.1038/sj.bjc.6603473
Regulation of mammalian horizontal gene transfer by apoptotic DNA fragmentation FREE
B Yan, H Wang, F Li and C-Y Li
Br J Cancer 95: 1696-1700; advance online publication, December 5, 2006; doi:10.1038/sj.bjc.6603484
Methylation of tumour suppressor genes APAF-1 and DAPK-1 and in vitro effects of demethylating agents in bladder and kidney cancer FREE
F Christoph, C Kempkensteffen, S Weikert, J Köllermann, H Krause, K Miller, M Schostak and M Schrader
Br J Cancer 95: 1701-1707; advance online publication, November 28, 2006; doi:10.1038/sj.bjc.6603482
Letter to the Editor
Are some breast cancers sexually transmitted? FREE
J S Lawson, C-Y Kan, B J Iacopetta and N J Whitaker
Br J Cancer 95: 1708; advance online publication, November 28, 2006; doi:10.1038/sj.bjc.6603502
Corrigendum
The significance of the time interval between antecedent pregnancy and diagnosis of high-risk gestational trophoblastic tumours FREE
T Powles, A Young, A Sanitt, J Stebbing, D Short, M Bower, P M Savage, M J Seckl and P Schmid
Br J Cancer 95: 1709; doi:10.1038/sj.bjc.6603536
Indexes
Author Index for Volume 95 FREE
Br J Cancer 95: 1710-1717; doi:10.1038/sj.bjc.6603540
Keyword Index for Volume 95 FREE
Br J Cancer 95: 1718-1721; doi:10.1038/sj.bjc.6603541
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
